Transcarent

Transcarent

On-demand medical access and delivery

Overview

Transcarent runs a digital health platform for individuals, families, and employers, offering 24/7 access to doctors via chat, personalized care guidance from health concierges, and doorstep medication delivery. Members join through employer plans or directly, then use the app or website to chat with doctors within 60 seconds, receive tailored care help, and order medicines to be shipped to their home. It differentiates itself by pairing immediate medical access with concierge support and cost transparency, supported by subscription options for employers and premium plans for individuals. The goal is to make healthcare less confusing, simpler to navigate, and more affordable by delivering easy access to care, trusted guidance, and clear information.

About Transcarent

Simplify's Rating
Why Transcarent is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consumer Software

Enterprise Software

Healthcare

Company Size

501-1,000

Company Stage

Series D

Total Funding

$424M

Headquarters

San Francisco, California

Founded

2020

Get referred to Transcarent

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 2026 Bluespine launched payment integrity, expanding Transcarent beyond navigation into claims savings.
  • June 2026 Anjali Jameson joined as CPO to accelerate AI product execution.
  • SmithRx and Capital Rx partnerships strengthen employer value by lowering drug costs now.

What critics are saying

  • June 2026 layoffs signal integration pressure after the Accolade merger closed.
  • Accolade investor investigations over the $621 million sale highlight process risk and distraction.
  • UnitedHealth, Optum, and CVS own adjacent navigation, benefits, and pharmacy decision layers.

What makes Transcarent unique

  • April 2025 Accolade merger gives Transcarent 20 million members and 1,700 clients.
  • January 2026 WayFinding added voice scheduling, symptom checking, and agentic AI actions.
  • April 2026 SmithRx integration makes pharmacy guidance real-time inside one member workflow.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$424M

Above

Industry Average

Funded Over

4 Rounds

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.
Series D Funding Comparison
Above Average

Industry standards

$77M
$70M
Twilio
$80M
Handshake
$100M
Affirm
$126M
Transcarent

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Unlimited Paid Time Off

Paid Vacation

Mental Health Support

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

-1%

2 year growth

-1%
PR Newswire
Jun 30th, 2026
SmithRx partners with Transcarent to bring real-time prescription cost intelligence into benefits navigation

SmithRx, a modern pharmacy benefits manager, has partnered with Transcarent to integrate prescription drug cost intelligence into Transcarent's WayFinding platform. The integration provides employees with real-time prescription cost estimates, pharmacy comparisons and lower-cost alternatives whilst giving employers visibility into drug spending. SmithRx's Drug Pathways Engine uses AI-powered technology to identify lower-cost medication options by analysing pricing data, plan rules and clinical criteria. The company works through directly contracted pharmacies and offers platform-based pricing, where every client receives identical pricing for medications. SmithRx reports average pharmacy benefit savings exceeding 20% and average per member per month savings of $37 across its client base. The partnership enables real-time pharmacy guidance within Transcarent's broader healthcare navigation experience, connecting medication decisions to related health resources and employer-sponsored benefits.

Business Wire
Jun 3rd, 2026
Transcarent names Anjali Jameson chief product officer to lead AI-powered healthcare platform

Transcarent, an AI-powered health and care platform, has appointed Anjali Jameson as Chief Product Officer. She will lead product strategy and innovation, focusing on using agentic AI embedded in Transcarent's WayFinding platform to improve care experiences for self-insured employers whilst reducing costs. Jameson brings extensive experience from building digital health products at Zipongo, Rally Health, UnitedHealth Group, Amazon/One Medical and Apple. She has led product and technology teams focused on scaling consumer healthcare experiences and leveraging AI to create personalised, connected healthcare solutions. In her new role, Jameson will oversee the WayFinding platform, which guides users through the healthcare system. Transcarent serves over 1,700 employers and health plans, supporting 21 million members.

Business Wire
Mar 17th, 2026
Transcarent partners with Bluespine to tackle $300B healthcare fraud with AI-powered payment integrity

Transcarent has launched a payment integrity category in its Experience Store through a partnership with Bluespine, an AI-driven health technology company. The initiative aims to help self-insured employers detect overbilling and reduce waste in healthcare spending. Fraud, waste and abuse account for an estimated 3% to 10% of total US healthcare spending, representing over $300 billion annually. Unlike traditional audits that review limited claim samples, Bluespine analyses 100% of medical and pharmacy claims using AI to identify overpayments, policy violations and billing errors. The platform supports both prepayment review and post-payment recovery, validating claims against employers' specific plan documents, coverage exclusions and negotiated rates. Every identified issue is documented with clear evidence tied to plan language or billing guidelines, enabling streamlined recovery without disrupting member experience.

Business Wire
Jan 9th, 2025
Transcarent To Acquire Accolade

Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, an

FinSMEs
May 2nd, 2024
Transcarent Raises $126M in Series D Funding

Transcarent, a San Francisco, CA-based healthcare platform provider, raised $126m in Series D funding

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Transcarent right now.

Find jobs on Simplify and start your career today

We update Transcarent's jobs every few hours, so check again soon! Browse all jobs →